Abstract
Introduction: It has been approved that vitamin D deficiency has a role in increasing the rate of cardio-vascular diseases in diabetic patients with unknown mechanism. The effects of vitamin D on hemostasis and its inflammatory mechanisms have been proposed as possible causes of cardio-vascular diseases in these patients. Also, high level of plasminogen activator inhibitor- type 1 (PAI-1) has been identified as a risk factor for cardio-vascular diseases in diabetic patients. The goal of this survey was to investigate the relation between vitamin D level and level of PAI-1 as a thrombotic marker.
Patients and Methods: 180 patients with type 2 diabetes mellitus enrolled for the study. The serum level of PAI-1 was measured by enzyme linked immune-assay and was compared with calcium metabolism markers including vitamin D, parathormon hormone, fasting blood sugar, calcium, and phosphorous.
Results: There was statistically significant relation between PAI-1 with fasting blood sugar and high density lipoprotein, but there was no significant relation between PAI-1 with vitamin D level and other cardio-vascular disease variables.
Discussion: It seems that serum level of vitamin D has no relation with PAI-1 in diabetic patients, although further investigations are required to confirm these findings.
Keywords: Cardio-vascular diseases, diabetes, plasminogen activator inhibitor-type 1 (PAI-1), thrombosis, vitamin D level.
Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:Correlation between Serum 25 hydroxy vitamin D level and plasminogen activator inhibitor 1 in type 2 diabetic patients
Volume: 13 Issue: 3
Author(s): Hassan Mansouritorghabe, Shokoufeh Bonakdaran and Seyed Javad Hossieni
Affiliation:
Keywords: Cardio-vascular diseases, diabetes, plasminogen activator inhibitor-type 1 (PAI-1), thrombosis, vitamin D level.
Abstract: Introduction: It has been approved that vitamin D deficiency has a role in increasing the rate of cardio-vascular diseases in diabetic patients with unknown mechanism. The effects of vitamin D on hemostasis and its inflammatory mechanisms have been proposed as possible causes of cardio-vascular diseases in these patients. Also, high level of plasminogen activator inhibitor- type 1 (PAI-1) has been identified as a risk factor for cardio-vascular diseases in diabetic patients. The goal of this survey was to investigate the relation between vitamin D level and level of PAI-1 as a thrombotic marker.
Patients and Methods: 180 patients with type 2 diabetes mellitus enrolled for the study. The serum level of PAI-1 was measured by enzyme linked immune-assay and was compared with calcium metabolism markers including vitamin D, parathormon hormone, fasting blood sugar, calcium, and phosphorous.
Results: There was statistically significant relation between PAI-1 with fasting blood sugar and high density lipoprotein, but there was no significant relation between PAI-1 with vitamin D level and other cardio-vascular disease variables.
Discussion: It seems that serum level of vitamin D has no relation with PAI-1 in diabetic patients, although further investigations are required to confirm these findings.
Export Options
About this article
Cite this article as:
Mansouritorghabe Hassan, Bonakdaran Shokoufeh and Hossieni Javad Seyed, Correlation between Serum 25 hydroxy vitamin D level and plasminogen activator inhibitor 1 in type 2 diabetic patients, Endocrine, Metabolic & Immune Disorders - Drug Targets 2013; 13 (3) . https://dx.doi.org/10.2174/18715303113139990038
DOI https://dx.doi.org/10.2174/18715303113139990038 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Histone Deacetylases: Anti-Angiogenic Targets in Cancer Therapy
Current Cancer Drug Targets Cytoprotection by Natural and Synthetic Polyphenols in the Heart: Novel Mechanisms and Perspectives
Current Pharmaceutical Design New Antihypertensive Drugs Under Development
Current Medicinal Chemistry The Importance of Early Diagnosis and Treatment in Peripheral Arterial Disease: Insights from the PARTNERS and REACH Registries
Current Vascular Pharmacology Lipid Nanocarriers and Molecular Targets for Malaria Chemotherapy
Current Drug Targets Vascular Mimicry: Concepts and Implications for Anti-Angiogenic Therapy
Current Angiogenesis (Discontinued) Near-Infrared Spectroscopy (NIRS): A Non-Invasive In Vivo Methodology for Analysis of Brain Vascular and Metabolic Activities in Real Time in Rodents
Current Vascular Pharmacology Site-related Effects of Relaxin in the Gastrointestinal Tract Through Nitric Oxide Signalling: An Updated Report
Current Protein & Peptide Science Oxidative Stress on Progenitor and Stem Cells in Cardiovascular Diseases
Current Pharmaceutical Biotechnology Tubulin Colchicine Binding Site Inhibitors as Vascular Disrupting Agents in Clinical Developments
Current Medicinal Chemistry The Role of the Novel Adipocyte-Derived Protein Adiponectin in Human Disease: An Update
Mini-Reviews in Medicinal Chemistry Vascular Inflammation and Atherosclerosis: The Role of Estrogen Receptors
Current Medicinal Chemistry Bone Loss and Osteoporosis are Associated with Conversion from Mild Cognitive Impairment to Alzheimer’s Disease
Current Alzheimer Research Metabolic Syndrome, Mild Cognitive Impairment and Dementia
Current Alzheimer Research Roles of Adrenomedullin in Hypertension and Hypertensive Organ Damage
Current Hypertension Reviews Matrix Gelatinases in Atherosclerosis and Diabetic Nephropathy: Progress and Challenges
Current Vascular Pharmacology Tocotrienols and Cardiovascular Health
Current Pharmaceutical Design Multiple Sclerosis: Pathogenesis and Treatment
Current Neuropharmacology Atherosclerotic Plaque Stabilization - Potential Role for Immunomodulatory Therapy
Vascular Disease Prevention (Discontinued) In the Rush for Green Gold: Can Green Tea Delay Age-Progressive Brain Neurodegeneration?
Recent Patents on CNS Drug Discovery (Discontinued)